Denis Larsimont
- Oncology top 0.1%
- Cancer Research top 0.1%
- Molecular Biology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Martine PiccartChristos SotiriouFátima CardosoChristine DesmedtAngelo Di LeoMauro DelorenziMarianne PaesmansBenjamin Haibe‐Kains
- Topics
- Breast Cancer Treatment Studies (71 papers)HER2/EGFR in Cancer Research (50 papers)Cancer Genomics and Diagnostics (39 papers)
In The Last Decade
Denis Larsimont
267 papers receiving 12.6k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 7.3k
- Cancer Research 5.3k
- Molecular Biology 4.8k
- Pulmonary and Respiratory Medicine 2.0k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Denis Larsimont
This map shows the geographic impact of Denis Larsimont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Larsimont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Larsimont more than expected).
Fields of papers citing papers by Denis Larsimont
This network shows the impact of papers produced by Denis Larsimont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Larsimont. The network helps show where Denis Larsimont may publish in the future.
Co-authorship network of co-authors of Denis Larsimont
This figure shows the co-authorship network connecting the top 25 collaborators of Denis Larsimont. A scholar is included among the top collaborators of Denis Larsimont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Larsimont. Denis Larsimont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 48 | |
| 7 | 19 | |
| 8 | 4 | |
| 9 | 7 | |
| 10 | 1 | |
| 11 | 110 | |
| 12 | 3 | |
| 13 | 55 | |
| 14 | Comprehensive molecular analysis of several prognostic signatures using molecular indices related to hallmarks of breast cancer: proliferation index appears to be the most significant component of all signatures | 2 |
| 15 | Topoisomerase II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with single-agent doxorubicin or single-agent docetaxel | 40 |
| 16 | HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil. | 216 |
| 17 | HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice. | 11 |
| 18 | Ganglion sentinelle et cancer invasif du sein: vers une nouvelle approche chirurgicale minimaliste. | 0 |
| 19 | Bcl-2 as a predictive marker for tamoxifen responsiveness in the adjuvant setting of node-positive breast cancer | 2 |
| 20 | Preoperative Axillary Immunolymphoscintigraphy (ilsc) in Breast-cancer Patients Using a 123-iodine Labeled Monoclonal-antibody (ab) | 1 |
About Denis Larsimont
Denis Larsimont is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 276 papers that have together received 12.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (71 papers), HER2/EGFR in Cancer Research (50 papers) and Cancer Genomics and Diagnostics (39 papers). The work is most often cited by research in Cancer Research (5.3k citations), Oncology (7.3k citations) and Pathology and Forensic Medicine (1.3k citations). Denis Larsimont has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Martine Piccart, Christos Sotiriou, Fátima Cardoso, Christine Desmedt, Angelo Di Leo, Mauro Delorenzi, Marianne Paesmans, Benjamin Haibe‐Kains, Virginie Durbecq and Marc Buyse. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.